Z-2333-2021 Class II Terminated
FDA device recall Z-2333-2021 was initiated by Becton, Dickinson And Company, BD Biosciences on Jul 22, 2021 and is designated Class II. Reason for recall: Complaints have been received for performance issues related to high background and staining. this issues is related to a manufacturing process error that can potentially cause a false positive… The recall status is terminated (terminated Mar 24, 2023). Affected quantity: 23 reagents.
Recall details
- Product Type
- Devices
- Report Date
- Sep 1, 2021
- Initiation Date
- Jul 22, 2021
- Termination Date
- Mar 24, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23 reagents
Product description
BD" Mouse IgG2a Isotype Control APC X39 ASR
Reason for recall
Complaints have been received for performance issues related to high background and staining. this issues is related to a manufacturing process error that can potentially cause a false positive staining due to contamination with another antibody.
Distribution pattern
Worldwide distribution - U.S. Nationwide distribution in the states of CT, FL, KY, NY, and PA. The country of Taiwan.
Code information
Catalog Number: 340757 UDI: 00382903407576 Lot Number: 0253432
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2333-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026